✦ LIBER ✦

Symptom-specific efficacy of tolterodine extended release in patients with overactive bladder: the IMPACT trial

✍ Scribed by V. ELINOFF; T. BAVENDAM; D. B. GLASSER; M. CARLSSON; N. EYLAND; R. ROBERTS

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tolterodine extended release improves pa

✍ R. ROBERTS; T. BAVENDAM; D. B. GLASSER; M. CARLSSON; N. EYLAND; V. ELINOFF 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB

Efficacy and tolerability of tolterodine

✍ VICTOR W. NITTI; ROGER DMOCHOWSKI; RODNEY A. APPELL; JOSEPH T. WANG; TAMARA BAVE 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB

The clinical efficacy of tolterodine ext

✍ Roger Dmochowski; Karl Kreder; Scott MacDiarmid; Martin Carlsson; Zhonghong Guan 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

Efficacy and tolerability of tolterodine

✍ CLAUS G. ROEHRBORN; PAUL ABRAMS; ERIC S. ROVNER; STEVEN A. KAPLAN; SENDER HERSCH 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 142 KB

Safety and efficacy of tolterodine exten

✍ K. Höfner; M. Burkart; G. Jacob; U. Jonas 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 277 KB

Long-term safety, tolerability and effic

✍ MINEO TAKEI; YUKIO HOMMA; THE JAPANESE TOLTERODINE STUDY GROUP 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB